Registry-listed formulations

This catalogue entry has no confirmed scientific concept.

Each study is counted once in the molecule profile. Registry products remain separate. Naming an ingredient does not establish that products are interchangeable or what participants received.

0 source entries across 0 studies. This list may not include all unresolved or historical entries.

    Success Metrics

    Clinical Success Rate
    100.0%

    Based on 2 completed trials

    Completion Rate
    100%(2/2)
    Active Trials
    0(0%)
    Results Posted
    0%(0 trials)

    Phase Distribution

    Not Applicable
    1
    33%
    Phase 1
    1
    33%
    Phase 3
    1
    33%

    Phase Distribution

    1

    Early Stage

    0

    Mid Stage

    1

    Late Stage

    Phase Distribution3 total trials
    Phase 1Safety & dosage
    1(33.3%)
    Phase 3Large-scale testing
    1(33.3%)
    N/ANon-phased studies
    1(33.3%)

    Highest Phase Reached

    Phase 3

    Trial Status & Enrollment

    Completion Rate

    66.7%

    2 of 3 finished

    Non-Completion Rate

    33.3%

    1 ended early

    Currently Active

    0

    trials recruiting

    Total Trials

    3

    all time

    Status Distribution
    Completed(2)
    Terminated(1)

    Detailed Status

    Completed2
    Withdrawn1

    Development Timeline

    Analytics

    Development Status

    Total Trials
    3
    Active
    0
    Success Rate
    100.0%
    Most Advanced
    Phase 3

    Trials by Phase

    Phase 11 (33.3%)
    Phase 31 (33.3%)
    N/A1 (33.3%)

    Trials by Status

    completed267%
    withdrawn133%

    Recent Activity

    0 active trials
    Showing 3 of 3
    withdrawnnot_applicable

    Anodal Transcranial Direct Current Stimulation of the Visual Cortex Versus Sham Stimulation in the Episodic Migraine

    NCT02122757
    completedphase_3

    Cathodal tDCS in Chronic Migraine: Neurophysiological Study and Pilot Therapeutic Trial

    NCT02122237
    completedphase_1

    Neurophysiological Study of tDCS Effects in Healthy Volunteers

    NCT02125422

    Clinical Trials (3)

    Showing 3 of 3 trials
    NCT02122757Not Applicable

    Anodal Transcranial Direct Current Stimulation of the Visual Cortex Versus Sham Stimulation in the Episodic Migraine

    Withdrawn
    NCT02122237Phase 3

    Cathodal tDCS in Chronic Migraine: Neurophysiological Study and Pilot Therapeutic Trial

    Completed
    NCT02125422Phase 1

    Neurophysiological Study of tDCS Effects in Healthy Volunteers

    Completed

    All 3 trials loaded

    Drug Details

    Intervention Type
    Device
    Total Trials
    3